↓ Skip to main content

Trial on Refinement of Early stage non-small cell lung cancer. Adjuvant chemotherapy with pemetrexed and cisplatin versus vinorelbine and cisplatin: The TREAT protocol

Overview of attention for article published in BMC Cancer, May 2007
Altmetric Badge

Mentioned by

policy
1 policy source

Citations

dimensions_citation
18 Dimensions

Readers on

mendeley
36 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Trial on Refinement of Early stage non-small cell lung cancer. Adjuvant chemotherapy with pemetrexed and cisplatin versus vinorelbine and cisplatin: The TREAT protocol
Published in
BMC Cancer, May 2007
DOI 10.1186/1471-2407-7-77
Pubmed ID
Authors

Michael Kreuter, Johan Vansteenkiste, Frank Griesinger, Hans Hoffmann, Hendrik Dienemann, Paul De Leyn, Michael Thomas

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 36 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 36 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 8 22%
Other 4 11%
Student > Bachelor 4 11%
Researcher 4 11%
Student > Ph. D. Student 2 6%
Other 5 14%
Unknown 9 25%
Readers by discipline Count As %
Medicine and Dentistry 13 36%
Nursing and Health Professions 8 22%
Biochemistry, Genetics and Molecular Biology 2 6%
Psychology 2 6%
Sports and Recreations 1 3%
Other 1 3%
Unknown 9 25%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 May 2022.
All research outputs
#7,536,586
of 22,994,508 outputs
Outputs from BMC Cancer
#2,095
of 8,355 outputs
Outputs of similar age
#25,460
of 72,360 outputs
Outputs of similar age from BMC Cancer
#7
of 15 outputs
Altmetric has tracked 22,994,508 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,355 research outputs from this source. They receive a mean Attention Score of 4.3. This one has gotten more attention than average, scoring higher than 68% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 72,360 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 16th percentile – i.e., 16% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 15 others from the same source and published within six weeks on either side of this one. This one is in the 13th percentile – i.e., 13% of its contemporaries scored the same or lower than it.